EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieStudienprotokoll

Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma

Anna Fosfuri, Giulia Orsi, Catia Carconi, Michele Milella, Letizia Procaccio, Ilario Giovanni Rapposelli, Katia Bencardino, Mario Scartozzi, Marina Macchini, Nicole Liscia, Luigi Carmine Leta, Barbara Merelli und 12 weitere

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.117033 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Anna Fosfuri und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salu…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Pancreatic Ductal, Guideline Adherence, Neoadjuvant Therapy. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Pancreatic DuctalGuideline AdherenceNeoadjuvant TherapyPancreatic NeoplasmsAgedFemaleHumansMaleMiddle AgedCapecitabineCisplatinDeoxycytidineFluorouracilGemcitabineIrinotecanLeucovorinOxaliplatinPaclitaxel

Stichwörter der Autor:innen

Borderline resectable pancreatic ductal adenocarcinomaDose intensityNeoadjuvant chemotherapyProtocol violationResectable pancreatic ductal adenocarcinoma

Substanzen

CapecitabineCisplatinDeoxycytidineFluorouracilfolfirinoxGemcitabineIrinotecanLeucovorinOxaliplatinPaclitaxel

Autor:innen und Institutionen

  • Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona, and Verona University and Hospital Trust, Verona, Italy.
  • Oncology 1 Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Niguarda Cancer Center, Department of Hematology, Oncology and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Zitieren

APA

Fosfuri, A., Orsi, G., Carconi, C., Milella, M., Procaccio, L., Rapposelli, I. G., Bencardino, K., Scartozzi, M., Macchini, M., Liscia, N., Leta, L. C., Merelli, B., Sperti, E., Bozzarelli, S., Di Marco, M., Tamburini, E., Bergamo, F., Malleo, G., Guarneri, G., …, & Reni, M. (2026). Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117033

Vancouver

Fosfuri A, Orsi G, Carconi C, Milella M, Procaccio L, Rapposelli IG, et al. Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.117033

BibTeX
@article{Fosfuri2026,
  author = {Fosfuri, Anna and Orsi, Giulia and Carconi, Catia and Milella, Michele and Procaccio, Letizia and Rapposelli, Ilario Giovanni and Bencardino, Katia and Scartozzi, Mario and Macchini, Marina and Liscia, Nicole and Leta, Luigi Carmine and Merelli, Barbara and Sperti, Elisa and Bozzarelli, Silvia and Di Marco, Mariacristina and Tamburini, Emiliano and Bergamo, Francesca and Malleo, Giuseppe and Guarneri, Giovanni and Aleotti, Francesca and Capurso, Gabriele and Arcidiacono, Paolo Giorgio and Falconi, Massimo and Reni, Michele},
  title = {Impact of center-level protocol adherence on neoadjuvant treatment outcome in pancreatic ductal adenocarcinoma},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.117033}
}
Kostenlos starten →